Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes

医学 外科 腔静脉 下腔静脉 系列(地层学) 机器人 人工智能 古生物学 计算机科学 生物
作者
Baojun Wang,Qingbo Huang,Kan Liu,Fan Yang,Cheng Peng,Liangyou Gu,Taoping Shi,Peng Zhang,Wenzheng Chen,Songliang Du,Shaoxi Niu,Rong Liu,Guodong Zhao,Qiuyang Li,Cangsong Xiao,Rong Wang,Shuanglei Li,Maoqiang Wang,Fengyong Liu,Haiyi Wang
出处
期刊:European Urology [Elsevier BV]
卷期号:78 (1): 77-86 被引量:92
标识
DOI:10.1016/j.eururo.2019.04.019
摘要

Level III-IV robot-assisted inferior vena cava (IVC) thrombectomy (RA-IVCT) has been reported in limited series. To report our initial series of level III-IV RA-IVCT with step-by-step procedures and 1-yr outcomes. From November 2014 to January 2018, 13 patients with level III-IV IVC tumor thrombi underwent RA-IVCT with a minimum of 1-yr follow-up. Level III RA-IVCT requires liver mobilization and clamping of first porta hepatis (FPH), and suprahepatic and infradiaphragmatic IVC. Level IV RA-IVCT requires establishment of cardiopulmonary bypass (CPB). Thoracoscopy-assisted thrombectomy was performed for the intra-atrium part of the thrombus under CPB. Infradiaphragmatic RA-IVCT was completed in a manner similar to that of level III RA-IVCT. Detailed techniques were described for various scenarios. Baseline and perioperative outcomes were reported, and descriptive statistical analysis was performed. Median operative time was 465 (interquartile range [IQR]: 338–567) min. Median estimated intraoperative blood loss was 2000 (IQR: 1000–3000) ml. The rates of intraoperative blood transfusion and postoperative transformation to the intensive care unit ward were 92.3% and 100%, respectively. Median FPH blocking time was 40 (IQR: 25–60) min and the CPB time was 72 (IQR: 51–87) min. Three cases had grade IV complications, including two vascular injuries that were treated with intraoperative endoscopic sutures and one perioperative death. The perioperative mortality rate was 7.7%. During an 18-mo follow-up, two patients died and one patient progressed. Although the risks involved are high, level III-IV RA-IVCT is feasible and serves as an alternative minimally invasive method for selected patients. It also requires more complex techniques and multidisciplinary cooperation. We studied the treatment of patients with level III-IV inferior vena cava (IVC) tumor thrombi using a robotic approach. This technique was feasible for well-selected patients. However, level III-IV robot-assisted IVC thrombectomy requires more complex techniques and multidisciplinary cooperation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
热情的外套完成签到,获得积分10
刚刚
mubibai发布了新的文献求助20
刚刚
刚刚
1秒前
顾矜的应助被科研通管家采纳,获得10
2秒前
汉堡包的应助被xiaxia采纳,获得10
2秒前
2秒前
英姑的应助被科研通管家采纳,获得30
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
酷波er的应助被科研通管家采纳,获得10
2秒前
小蘑菇的应助被走四方采纳,获得10
2秒前
Hello的应助被科研通管家采纳,获得10
2秒前
渡人舟的应助被科研通管家采纳,获得10
2秒前
充电宝的应助被科研通管家采纳,获得10
2秒前
今后的应助被科研通管家采纳,获得10
2秒前
2秒前
OK的应助被科研通管家采纳,获得100
3秒前
打打的应助被科研通管家采纳,获得10
3秒前
Jasper的应助被科研通管家采纳,获得30
3秒前
OK的应助被科研通管家采纳,获得80
3秒前
西西红柿的应助被科研通管家采纳,获得10
3秒前
3秒前
3秒前
英俊的铭的应助被科研通管家采纳,获得10
3秒前
3秒前
充电宝的应助被科研通管家采纳,获得10
3秒前
梦想彩虹关注了科研通微信公众号
4秒前
路口发布了新的文献求助10
4秒前
ZW发布了新的文献求助10
4秒前
木小虫发布了新的文献求助10
5秒前
qr完成签到,获得积分10
5秒前
5秒前
5秒前
嘉柏完成签到,获得积分10
6秒前
黑森林发布了新的文献求助10
6秒前
7秒前
8秒前
qkdxh发布了新的文献求助10
9秒前
Yuan发布了新的文献求助10
10秒前
yangyucheng发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
Final Report for the 2-D Test of Model 901 Rotor and Wing Airfoils (BSWT 592) 528
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 520
Organizational Behavior 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7886439
求助须知:如何正确求助?哪些是违规求助? 9398836
关于积分的说明 20828945
捐赠科研通 7488833
什么是DOI,文献DOI怎么找? 3356539
关于科研通互助平台的介绍 2495279
邀请新用户注册赠送积分活动 2384610